Acute Graft-vs-Host Disease After Liver Transplantation: Experience at a High-volume Liver Transplantation Center in Korea

  • Kang W.H.; 
  • Hwang S.; 
  • Song G.W.; 
  • Jung D.H.; 
  • Park G.C.; 
  • ... Kim W.J.; 
  • 외 9명
Citations

WEB OF SCIENCE

15
Citations

SCOPUS

16

초록

Background Acute graft-vs-host disease (GVHD) is a rare but life-threatening complication of orthotopic liver transplantation (OLT). We present 6 cases of GVHD after OLT. Methods Among our 4294 OLT recipients, we identified 6 patients (0.14%) who were diagnosed with GVHD. Their medical records were reviewed retrospectively. Results Liver graft types included deceased donor whole liver graft (n = 3) and right liver graft from son (n = 3). Mean recipient and donor ages were 57.2 ± 6.6 years and 32.7 ± 10.8 years, respectively. Onset of GVHD symptoms occurred 14 to 32 days after OLT, and initial symptoms were skin rash (n = 5) and fever (n = 1). GVHD was pathologically confirmed by skin or rectal biopsy. Chimerism of donor lymphocytes was identified in all 3 patients who underwent the short tandem repeat polymerase chain reaction assay. Attempts were made to treat the GVHD in all 6 patients by corticosteroids with or without low-dose calcineurin inhibitor, but we had to stop early or reduce these agents due to aggravation of pancytopenia and septic complications. Ultimately, 5 patients died 6 to 106 days after the onset of GVHD, and only 1 patient recovered. This surviving patient was diagnosed earlier and had been administered the recommended dosage of corticosteroid for a longer period with aggressive infection prophylaxis compared to the other cases. Conclusions Because of very poor outcomes of GVHD after OLT, early diagnosis and vigorous treatment should be emphasized, although no effective treatment modality has been established yet. We strongly suggest performing aggressive infection prophylaxis during GVHD treatment. © 2016 Elsevier Inc.

키워드

antibiotic agent; antifungal agent; antivirus agent; calcineurin inhibitor; corticosteroid; macrophage activating factor; methylprednisolone; tacrolimus; corticosteroid; microsatellite DNA; acute graft versus host disease; adult; Article; chimera; colon biopsy; controlled study; corticosteroid therapy; diarrhea; drug megadose; fever; human; human tissue; immunosuppressive treatment; infection prevention; infectious complication; liver graft; liver transplantation; low drug dose; lymphocyte; major clinical study; medical record review; middle aged; neutropenia; pancytopenia; polymerase chain reaction; priority journal; rash; recommended drug dose; rectum biopsy; retrospective study; sepsis; short tandem repeat; skin biopsy; son; surgical infection; treatment outcome; adverse effects; aged; case report; donor; fatality; genetics; Graft vs Host Disease; liver transplantation; male; South Korea; time to treatment; Adrenal Cortex Hormones; Aged; Chimerism; Fatal Outcome; Graft vs Host Disease; Humans; Liver Transplantation; Male; Microsatellite Repeats; Middle Aged; Polymerase Chain Reaction; Republic of Korea; Retrospective Studies; Time-to-Treatment; Tissue Donors; Treatment Outcome
제목
Acute Graft-vs-Host Disease After Liver Transplantation: Experience at a High-volume Liver Transplantation Center in Korea
저자
Kang W.H.; Hwang S.; Song G.W.; Jung D.H.; Park G.C.; Ahn C.S.; Moon D.B.; Kim K.H.; Ha T.Y.; Kim W.J.; Kim S.H.; Cho H.D.; Kwon J.H.; Jwa E.K.; Lee S.G.
DOI
10.1016/j.transproceed.2016.08.051
발행일
2016-12
유형
Article
저널명
Transplantation Proceedings
권
48
호
10
페이지
3368 ~ 3372